IMMUNITAS THERAPEUTICS Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for IMMUNITAS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IMMUNITAS THERAPEUTICS trademark a serial number of 88984877. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by Immunitas Therapeutics, Inc.. The IMMUNITAS THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders

General Information

Serial Number88984877
Word MarkIMMUNITAS THERAPEUTICS
Filing DateWednesday, December 18, 2019
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6997137
Registration DateTuesday, March 7, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Description of MarkThe mark consists of two concentric three-quarter circles formed with dashes and dots, with the last quarter-circle on the top right formed by single large dots. The word "Immunitas" in large font extends from within the center of the circles and "THERAPEUTICS" in small font is outside of the semi-circles below the letters "munitas".
Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 21, 2019
Primary Code005
First Use Anywhere DateFriday, September 30, 2022
First Use In Commerce DateFriday, September 30, 2022

Trademark Owner History

Party NameImmunitas Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunitas Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunitas Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, December 21, 2019NEW APPLICATION ENTERED
Saturday, December 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Tuesday, March 17, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, March 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2020ASSIGNED TO LIE
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 16, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020SOU EXTENSION 1 FILED
Wednesday, December 16, 2020SOU EXTENSION 1 GRANTED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021SOU TEAS EXTENSION RECEIVED
Monday, June 21, 2021SOU EXTENSION 2 FILED
Monday, June 21, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 20, 2021SOU EXTENSION 3 FILED
Monday, December 20, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 6, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 6, 2022SOU EXTENSION 4 FILED
Friday, May 6, 2022SOU EXTENSION 4 GRANTED
Tuesday, May 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, December 1, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 1, 2022TEAS REQUEST TO DIVIDE RECEIVED
Thursday, December 1, 2022DIVISIONAL REQUEST RECEIVED
Thursday, December 1, 2022SOU EXTENSION 5 FILED
Thursday, December 1, 2022USE AMENDMENT FILED
Tuesday, January 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 3, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, January 3, 2023SOU EXTENSION 5 GRANTED
Tuesday, January 3, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 31, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 1, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics immunitas diseases disorders inflammatory autoimmune cancer preparations prevention treatment pharmaceutical